DNTHDianthus Therapeutics, Inc.
$82.35+124% 1Y
$82.35
$32.9252 weeks$115.67
Is it growing?
Is DNTH growing?
Dianthus Therapeutics, Inc. has grown revenue −32% a year over three years.
−32%
Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from fiscal-year columns as filed
- Years of annual history on file
- 10
Years of annual history on file · FY2016 to FY2025, as filed
Details›
- Revenue FY2021
- $1.5M
- Revenue FY2022
- $6.4M
- Revenue FY2023
- $2.8M
- Revenue FY2024
- $6.2M
- Revenue FY2025
- $2.0M
Annual income statements as filed with the SEC.
On our screens:Most shorted stocks